Theriva Biologics, Inc. Dividends, Preferred Stock, Paid-in-kind
Theriva Biologics, Inc. (TOVX) reported Dividends, Preferred Stock, Paid-in-kind of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Shareholders' Equity › Dividends, Preferred Stock
us-gaap:DividendsPreferredStockPaidinkind · last filed 2023-03-30
- Theriva Biologics, Inc. dividends, preferred stock, paid-in-kind for the quarter ending 2022-12-31 was $0.00.
- Theriva Biologics, Inc. dividends, preferred stock, paid-in-kind for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Theriva Biologics, Inc. dividends, preferred stock, paid-in-kind for the quarter ending 2022-06-30 was $0.00.
- Theriva Biologics, Inc. dividends, preferred stock, paid-in-kind for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Theriva Biologics, Inc. dividends, preferred stock, paid-in-kind for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Theriva Biologics, Inc. dividends, preferred stock, paid-in-kind for fiscal 2021 was $24.00K, a 90.55% decline from fiscal 2020.
- Theriva Biologics, Inc. dividends, preferred stock, paid-in-kind for fiscal 2020 was $254.00K, a 2.42% increase from fiscal 2019.
- Theriva Biologics, Inc. dividends, preferred stock, paid-in-kind for fiscal 2019 was $248.00K, a 2.06% increase from fiscal 2018.
| Period end | Dividends, Preferred Stock, Paid-in-kind 3 month | Dividends, Preferred Stock, Paid-in-kind 6 month | Dividends, Preferred Stock, Paid-in-kind 9 month | Dividends, Preferred Stock, Paid-in-kind 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | $0.00 10-K · filed 2023-03-30 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | $0.00 derived: sum of 4 quarters · filed 2023-03-30 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | $1.00K derived: sum of 4 quarters · filed 2023-03-30 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $1.00K derived: sum of 3 quarters · filed 2023-03-30 | $1.00K derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.00K derived: sum of 2 quarters · filed 2023-03-30 | $1.00K derived: sum of 3 quarters · filed 2023-03-30 | $24.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.00K derived: sum of 2 quarters · filed 2022-11-10 | $24.00K 10-Q · filed 2022-11-10 | $89.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $23.00K 10-Q · filed 2022-08-11 | $88.00K derived: sum of 3 quarters · filed 2022-08-11 | $152.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $23.00K 10-Q · filed 2022-05-16 | $88.00K derived: sum of 2 quarters · filed 2022-05-16 | $152.00K derived: sum of 3 quarters · filed 2022-05-16 | $215.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | $129.00K derived: sum of 2 quarters · filed 2022-03-16 | $192.00K derived: sum of 3 quarters · filed 2022-03-16 | $254.00K 10-K · filed 2022-03-16 |
| 2020-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $127.00K derived: sum of 2 quarters · filed 2021-11-03 | $189.00K 10-Q · filed 2021-11-03 | $252.00K derived: sum of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | $63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $125.00K 10-Q · filed 2021-08-05 | $188.00K derived: sum of 3 quarters · filed 2021-08-05 | $251.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $62.00K 10-Q · filed 2021-05-05 | $125.00K derived: sum of 2 quarters · filed 2021-05-05 | $188.00K derived: sum of 3 quarters · filed 2021-05-05 | $249.00K derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $126.00K derived: sum of 2 quarters · filed 2021-03-04 | $187.00K derived: sum of 3 quarters · filed 2021-03-04 | $248.00K 10-K · filed 2021-03-04 |
| 2019-09-30 | $63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $124.00K derived: sum of 2 quarters · filed 2020-11-10 | $185.00K 10-Q · filed 2020-11-10 | $247.00K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $122.00K 10-Q · filed 2020-08-06 | $184.00K derived: sum of 3 quarters · filed 2020-08-06 | $245.00K derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $61.00K 10-Q · filed 2020-05-05 | $123.00K derived: sum of 2 quarters · filed 2020-05-05 | $184.00K derived: sum of 3 quarters · filed 2020-05-05 | $245.00K derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $123.00K derived: sum of 2 quarters · filed 2020-02-20 | $184.00K derived: sum of 3 quarters · filed 2020-02-20 | $243.00K 10-K · filed 2020-02-20 |
| 2018-09-30 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $122.00K derived: sum of 2 quarters · filed 2019-11-04 | $181.00K 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $120.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $59.00K 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | $73.00K 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |